A prospective study of age trends of high-risk human papillomavirus infection in rural China

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Kang, Le Ni ^a   Castle, Philip E ^b   Zhao, Fang Hui ^a   Jeronimo, Jose ^c   Chen, Feng ^a   Bansil, Pooja ^c   Li, Jing ^a   Chen, Wen ^a   Zhang, Xun ^a   Qiao, You Lin ^a  

^a CANCER HOSPITAL   (China)

^b Global Cancer Initiative   (United States)

^c PATH   (United States)

Author keywords

Age; Cohort effect; Human papillomavirus; Infection; Risk factor

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CHINA; DISEASE CLEARANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; MORBIDITY; PAPILLOMAVIRUS INFECTION; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; RURAL AREA; TREND STUDY; YOUNG ADULT; FOLLOW UP; INCIDENCE; MASS SCREENING; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; RURAL POPULATION; UTERINE CERVICAL NEOPLASMS;

VIRUS DNA;

ADULT; AGE FACTORS; AGED; CHINA; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; RURAL POPULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84894627479     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-96     Document Type: Article

References (49)

1. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007, 370:890-907. 10.1016/S0140-6736(07)61416-0, 17826171.
2. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366:991-998. 10.1016/S0140-6736(05)67069-9, 16168781.
3. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006, 119:2677-2684. 10.1002/ijc.22241, 16991121.
4. Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, Vaccarella SV, Jara AT, Puschel KI, Robles SC, et al. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 2004, 13:2271-2276.
5. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005, 191:1796-1807. 10.1086/428850, 15871111.
6. Peto J, Gilham C, Deacon J, Taylor C, Evans C, Binns W, Haywood M, Elanko N, Coleman D, Yule R, et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer 2004, 91:942-953. 2409880, 15292939.
7. Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008, 123:1864-1870. 10.1002/ijc.23712, 18661520.
8. Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJ, Huang RD, Sun LX, Meijer CJ, Qiao YL, et al. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 2006, 95:96-101. 10.1038/sj.bjc.6603208, 2360486, 16773069.
9. Li LK, Dai M, Clifford GM, Yao WQ, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Qiao YL, et al. Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study. Br J Cancer 2006, 95:1593-1597. 10.1038/sj.bjc.6603450, 2360733, 17088908.
10. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, et al. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer 2007, 121:1306-1311. 10.1002/ijc.22726, 17417776.
11. Liu SS, Chan KY, Leung RC, Chan KK, Tam KF, Luk MH, Lo SS, Fong DY, Cheung AN, Lin ZQ, et al. Prevalence and risk factors of Human Papillomavirus (HPV) infection in southern Chinese women - a population-based study. PLoS One 2011, 6:e19244. 10.1371/journal.pone.0019244, 3086888, 21559276.
12. Yu XW, Zhang XW, Wang L, Li F, Xu J. Status of human papillomavirus infection in the rural female population in Northwestern China: an observational study. J Low Genit Tract Dis 2013, 17:17-22. 10.1097/LGT.0b013e31825707ab, 22885647.
13. Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, Wu RF, Li CQ, Wei LH, Xu AD, et al. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer 2012, 131:2929-2938. 10.1002/ijc.27571, 3435460, 22488743.
14. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F, 10451482.
15. Boulet GA, Horvath CA, Berghmans S, Bogers J. Human papillomavirus in cervical cancer screening: important role as biomarker. Cancer Epidemiol Biomarkers Prev 2008, 17:810-817. 10.1158/1055-9965.EPI-07-2865, 18398022.
16. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55:244-265. 10.1136/jcp.55.4.244, 1769629, 11919208.
17. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM, ALTS Group A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 2007, 195:1582-1589. 10.1086/516784, 17471427, ALTS Group.
18. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol 2008, 168:123-137. 10.1093/aje/kwn036, 2878094, 18483125.
19. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012, 137:516-542. 10.1309/AJCPTGD94EVRSJCG, 22431528.
20. Gage JC, Ajenifuja KO, Wentzensen N, Adepiti AC, Stoler M, Eder PS, Bell L, Shrestha N, Eklund C, Reilly M, et al. Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria. Int J Cancer 2012, 131:2903-2909. 10.1002/ijc.27563, 3404249, 22473652.
21. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008, 9:929-936. 10.1016/S1470-2045(08)70210-9, 18805733.
22. Zhao FH, Jeronimo J, Qiao YL, Schweizer J, Chen W, Valdez M, Lu P, Zhang X, Kang LN, Bansil P, et al. An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China. Cancer Prev Res (Phila) 2013, 6:938-948. 10.1158/1940-6207.CAPR-13-0091, 23878179.
23. Pretorius RG, Zhang WH, Belinson JL, Huang MN, Wu LY, Zhang X, Qiao YL, et al. Colposcopy directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004, 191:430-434. 10.1016/j.ajog.2004.02.065, 15343217.
24. Gravitt PE, Burk RD, Lorincz A, Herrero R, Hildesheim A, Sherman ME, Bratti MC, Rodriguez AC, Helzlsouer KJ, Schiffman M. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol biomarkers Prev 2003, 12:477-484.
25. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. Series: No 31 2001, 10. Geneva: World Health Organization Press, [www.who.int/healthinfo/paper31.pdf].
26. Moodley JR, Constant D, Hoffman M, Salimo A, Allan B, Rybicki E, Hitzeroth I, Williamson AL, et al. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. BMC Cancer 2009, 9:275. 10.1186/1471-2407-9-275, 2739859, 19664216.
27. Safaeian M, Herrero R, Hildesheim A, Quint W, Freer E, Van Doorn LJ, Porras C, Silva S, González P, Bratti MC, et al. Comparison of the SPF10-LiPA system to the hybrid capture 2 assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica. J Clin Microbiol 2007, 45:1447-1454. 10.1128/JCM.02580-06, 1865890, 17344361.
28. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008, 43(4 Suppl):S5-S25.
29. Collins S, Mazloomzadeh S, Winter H, Blomfield P, Bailey A, Young LS, Woodman CB. High incidence of cervical human papillomavirus infection in women during their first sexual relationship. BJOG 2002, 109:96-98. 10.1111/j.1471-0528.2002.01053.x, 11845815.
30. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003, 157:218-226. 10.1093/aje/kwf180, 12543621.
31. Rodriguez AC, Burk R, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillen D, Alfaro M, Viscidi R, et al. The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life. Sex Transm Dis 2007, 34:494-502.
32. Moscicki AB. Management of adolescents who have abnormal cytology and histology. Obstet Gynecol Clin North Am 2008, 35:633-643. 10.1016/j.ogc.2008.09.004, 2766533, 19061822.
33. Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005, 191:1808-1816. 10.1086/428779, 15871112.
34. Wang C. History of the Chinese family planning progrom: 1970-2010. Contraception 2012, 85:563-569. 10.1016/j.contraception.2011.10.013, 22176797.
35. Wei K, Wang Y, Liang Z. An analysis of incidence with cervical cancer in 1970 ~ 2007 in Zhongshan city, Guangdong province. China Cancer 2012, 21:495-497. in Chinese.
36. Sharma M, Bruni L, Diaz M, Castellsagué X, de Sanjosé S, Bosch FX, Kim JJ. Using HPV prevalence to predict cervical cancer incidence. Int J Cancer 2013, 132:1895-1900. 10.1002/ijc.27835, 22965284.
37. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, Ning L, Killeen J, Kamemoto L, Hernandez BY. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii human papillomavirus cohort study. Cancer Res 2008, 68:8813-8824. 10.1158/0008-5472.CAN-08-1380, 2727731, 18974124.
38. Gravitt PE, Rositch AF, Silver MI, Marks MA, Chang K, Burke AE, Viscidi RP. A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States. J Infect Dis 2012, 207:272-280. 3532829, 23242540.
39. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, 26(Suppl 1):K1-K16.
40. Strickler HD, Kirk GD, Figueroa JP, Ward E, Braithwaite AR, Escoffery C, Drummond J, Goebel B, Waters D, McClimens R, et al. HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates. Int J Cancer 1999, 80:339-344. 10.1002/(SICI)1097-0215(19990129)80:3<339::AID-IJC1>3.0.CO;2-F, 9935171.
41. González P, Hildesheim A, Rodríguez AC, Schiffman M, Porras C, Wacholder S, Piñeres AG, Pinto LA, Burk RD, Herrero R. Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Cancer Epidemiol Biomarkers Prev 2010, 19:3044-3054. 10.1158/1055-9965.EPI-10-0645, 3703390, 20952561.
42. Lai CH, Chao A, Chang CJ, Chao FY, Huang HJ, Hsueh S, Lin CT, Cheng HH, Huang CC, Yang JE, et al. Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in Taiwan. Int J Cancer 2008, 123:1685-1692. 10.1002/ijc.23679, 18623128.
43. Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, Sparrow J, Lorincz A, et al. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 2003, 168:421-425. 143547, 12591782.
44. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010, 11:1048-1056. 10.1016/S1470-2045(10)70230-8, 20952254.
45. The Lancet: Women's health in rural China. Lancet 2009, 374:358.
46. Méndez F, Muñoz N, Posso H, Molano M, Moreno V, van den Brule AJ, Ronderos M, Meijer C, Muñoz A, et al. Cervical coinfection with Human Papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 2005, 192:1158-1165. 10.1086/444391, 16136457.
47. Rositch AF, Koshiol J, Hudgens MG, Razzaghi H, Backes DM, Pimenta JM, Franco EL, Poole C, Smith JS. Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer 2013, 133:1271-1285. 10.1002/ijc.27828, 22961444.
48. Rodríguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, Castle PE, Solomon D, Burk R. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 2008, 100:513-517. 10.1093/jnci/djn044, 3705579, 18364507.
49. Castle PE, Rodriguez AC, Burk RD, Herrero R, Wacholder S, Alfaro M, Morales J, Guillen D, Sherman ME, Solomon D, et al. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ 2009, 339:b2569. 10.1136/bmj.b2569, 2718087, 19638649.